Emily Musing is an Associate Professor (status) with the Leslie Dan Faculty of Pharmacy and a Senior Fellow at the Institute of Health Policy Management and Evaluation (IHPME), University of Toronto (U of T). Prior to retirement, she was University Health Network (UHN)'s Chief
Patient Safety Officer and VP, Clinical leading Pharmacy, Infection Prevention and Control, Antimicrobial Stewardship, Patient Safety and UHN's Caring Safely initiative and COVID-19 Vaccine Strategy. Emily was the Faculty's inaugural Leader-in-Residence for 2022-23 and developed a Leadership Intensive for third-year pharmacy students.
Emily received her Bachelor of Science in Pharmacy from U of T (1983) and
completed a post-graduate Hospital Pharmacy Practice Residency at Mount Sinai Hospital. She attained her Master of Health Science in Health Administration from IHPME, UofT (2003). Emily was previously President of the Canadian Society of Hospital Pharmacists, Chief Administrator for the Pharmacy Examining Board of Canada's Toronto Objective Structured Clinical Examination and an assessor for the Ontario College of Pharmacists' Quality Assurance Practice Review. She served as Vice Chair of the Death Investigation Oversight Council reporting to the Ministry of Community Safety and Correctional Services. Emily sat on the boards of the Institute for Safe Medication Practices, Canada, the Canadian Patient Safety
Institute, Canadian Hospital Pharmacy Residency Board and was the Executive Editor for the Hospital Pharmacy in Canada Report. She also sat on the U of T/Toronto Academic Health Science Network Joint Task Force for Valuing Academic Performance, and on the Avoidable Hospitalization Advisory Panel reporting to the Ministry of Health and Long-Term Care.
Keywords: leader-in-residence, quality and safety, COVID, vaccine strategy
